Clinical Trial Update: Dosimetry of Tc-99m-Tilmanocept [Phase 1]

View source ↗

Summary

A Phase 1 trial to assess the dosimetry of Tc-99m-Tilmanocept in diabetic nephropathy, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy

Drugs mentioned

• Tc-99m-Tilmanocept (tilmanocept)

Snippet

Sponsor: University of California, San Diego | Conditions: Diabetic Kidney Disease | Phase 1 | Status: RECRUITING